In accordance with our in silico analysis of clinical NSCLCs, mRNA levels of TBX4 and TBX5 exhibited more pronounced suppression in NSCLC cell lines, particularly when cells were cultured in reduced serum conditions, compared with levels of TBX2 and TBX3 (Figure 3). This evidence concerns the gene TBX2 and non-small cell lung carcinoma.